BLAZER II XP CATHETERS
FDA premarket approval P020025/S018 · decided 2006-12-21
Approval details
- PMA number
- P020025
- Supplement
- S018
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- BLAZER II XP CATHETERS
- Generic name
- catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
- Applicant
- Boston Scientific
- Date received
- 2006-09-21
- Decision date
- 2006-12-21
- Days to decision
- 91 days
- Decision code
- APPR
- Product code
- OAD
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- APPROVAL FOR MODIFICATION OF THE STEERING MECHANISM FOR THE N4 CURVE VERSION OF THE BLAZER II XP CATHETERS AND THE USE OF A NEW SOLDERING FIXTURE IN THE MANUFACTURING PROCESS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.